We are not just here to pick outliers, we are here to help build them

Our People

At Amiti, investment is personal. We are not just here to pick outliers — we are here to help build them.

We back companies at the earliest inflection points — when the science is still emerging, the product undefined, and the path uncertain. That is where we thrive.
With decades of deep tech investing, operational, and technical expertise, we know how to spot rare potential early — and how to turn it into real, compounding value.

We are a small, focused team by design — supported by a deep bench of experts that gives us the flexibility where science is going. Our size keeps us sharp, close to the founders, and deeply involved in the journey.
We go deep not just on ideas, but on people — because every great company starts with a rare kind of founder, and a team that sees them clearly from the start.

We move early, think long, and show up fully. Because the best companies are not just backed, they are built.

These are the people behind the thesis, and beside the founders building the future and delivering outlier returns.

Ben Rabinowitz

Founder,  CEO & CIO

Yafit Schwartz

General Partner & COO

Noora Kattouf

Principal

Nirit Shasho

Accountant
Ben Rabinowitz
Founder,  CEO & CIO
Yafit Schwartz
General Partner & COO
Noora Kattouf
Principal
Nirit Shasho
Accountant
Liat Cohen Slor
Communications & IR Coordinator
Tal Ben-David
Accounting Controller

Liat Cohen Slor

Investor Relations

Tal Ben-David

Accounting Controller

Our Expert
Network

Amiti has a team of advisors with expertise in quantum computing, quantum methods, AI, tech bio, and more
Raja Doddala
Advisor and Portfolio Board Member
Dr. Sivan Refaely Abramson
Scientific Advisor
Robert Matles
Advisor, Quantum Applications
Dr. Juan Alzate
Advisor, Tech-bio

Raja Doddala

Advisor and Portfolio Borad Member

Dr. Sivan Refaely Abramson

Scientific Advisor

Robert Matles

Advisor, Quantum Applications

Dr. Juan Alzate

Advisor, Tech-bio
Our Partners
AION Labs is another prime example, a venture studio backed by Amiti, focused on applying AI and computational science to solve the hardest challenges in drug discovery.

Backed by global pharma leaders; with leading scientists from
AstraZeneca, Merck, Pfizer, Teva , AWS, and supported by the Israeli government, it bridges academia and industry to launch cutting-edge AI startups.